3,232
Participants
Start Date
September 30, 2013
Primary Completion Date
August 31, 2014
Study Completion Date
August 31, 2014
pegnivacogin/anivamersen
Bivalirudin
Black Hills Cardiovascular Research, Rapid City
Collaborators (2)
The Cleveland Clinic
OTHER
Duke Clinical Research Institute
OTHER
Canadian VIGOUR Centre
OTHER
Icahn School of Medicine at Mount Sinai
OTHER
Parexel
INDUSTRY
Regado Biosciences, Inc.
INDUSTRY